Browse 25 famous antibodies, edit CDRs, score developability
A molecular playground for antibody engineers. Browse 25 curated antibodies (Trastuzumab, Pembrolizumab, Adalimumab, plus bispecifics, ADCs, and nanobodies), edit heavy and light chain CDRs with live highlighting, compute humanness against human germlines, and score six-axis developability including solubility, viscosity, immunogenicity, aggregation, and thermostability.
POST /v1/antibody-lab/calculate/propertiesimport requests
# List the 25-antibody library
r = requests.get("https://scirouter.ai/v1/antibody-lab/antibodies")
print(r.json()["data"]["total"]) # 25
# Calculate properties for a heavy + light chain pair
response = requests.post(
"https://scirouter.ai/v1/antibody-lab/calculate/properties",
json={
"heavy_chain": "EVQLVESGGGLVQPGGSLRLSCAAS...", # Trastuzumab VH
"light_chain": "DIQMTQSPSSLSASVGDRVTITCRAS..." # Trastuzumab VL
}
)
p = response.json()["data"]
print(f"MW: {p['molecular_weight']/1000:.1f} kDa")
print(f"pI: {p['isoelectric_point']:.2f}")
# Score humanness
h = requests.post(
"https://scirouter.ai/v1/antibody-lab/humanness",
json={"heavy_chain": "EVQLVESGGGLVQPGGSLRLSCAAS..."}
)
print(f"Humanness: {h.json()['data']['overall_humanness']:.2f}")Teach CDR structure and antibody humanization
Rapidly prototype CDR-H3 variants before committing to synthesis
Compare checkpoint inhibitors (Pembrolizumab vs Nivolumab vs Atezolizumab)
Visualize bispecific architecture (Blinatumomab BiTE, Teclistamab)
Explore nanobody chemistry (Caplacizumab, Ozoralizumab)
12 min read
11 min read
13 min read
11 min read
11 min read